瘤微环境响应纳米粒子放大癌症免疫疗法的STING信号通路
Dan Liu1,2, Shuang Liang1,2, Kongshuo Ma1,2
1State Key Laboratory of Bioactive Substance and Function of Natural Medicines, Institute of Materia Medica, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing, 100050, China.
Advanced materials (Deerfield Beach, Fla.)
|September 19, 2023
概括
响应瘤微环境的纳米颗粒激活STING和TLR4通路,增强I型干扰素的产生和T细胞的反应. 这种方法克服了免疫抑制,提高了癌症免疫疗法的疗效,产生了持久的抗瘤记忆.
科学领域:
- 免疫学 免疫学 免疫学
- 纳米技术纳米技术
- 在瘤学瘤学.
背景情况:
- 癌症免疫疗法受到不足的STING通路激活和免疫抑制瘤微环境的限制.
- 向STING和Toll-like受体4 (TLR4) 提供了增强抗瘤免疫力的潜力.
研究的目的:
- 开发适应瘤微环境 (TME) 的纳米粒子 (PMM NPs),同时激活STING和TLR4.
- 调查PMMNP克服TME介导免疫抑制和增强自适应性免疫反应的潜力.
- 在临床前癌症模型中评估PMMNP与抗PD-1疗法相结合的协同效果.
主要方法:
- 设计和合成TME响应纳米粒子 (PMM NP).
- 在体外和体内评估STING和TLR4激活.
- 对细胞因子分泌 (例如,IFN-β) 和免疫细胞群 (T细胞,巨细胞) 的分析.
- 在结直肠和乳腺癌模型中评估治疗疗效,包括与抗PD-1的联合治疗.
主要成果:
- 通过TLR4介导的NF-κB信号传递,PMM NPs显著增强了STING激活,I型干扰素 (IFN-β) 的分泌量增加了4.0倍.
- 通过减少调节性T细胞和两极化M2巨细胞到M1,促进免疫支持环境,PMMNP调节了TME.
- 与PMMNP和抗PD-1抗体的联合治疗在炎症和非炎症瘤模型中都显示出协同效果.
- 挑战无瘤动物诱导了完全的瘤排斥,表明系统性抗瘤记忆的发展.
结论:
- 响应TME的纳米粒子为STING激活的时空编排提供了一种新的策略.
- 这种方法通过克服免疫抑制和促进自适应性免疫反应,有效增强抗瘤免疫力.
- PMM NPs代表了下一代癌症免疫治疗的有希望的临床候选人,可能导致持久的反应和记忆.
更多相关视频
07:55Flow Cytometry-Based Isolation and Therapeutic Evaluation of Tumor-Infiltrating Lymphocytes in a Mouse Model of Pancreatic Cancer
Published on: January 17, 2025
844
08:19Transfer of Manipulated Tumor-associated Neutrophils into Tumor-Bearing Mice to Study their Angiogenic Potential In Vivo
Published on: July 20, 2019
6.0K
相关概念视频
The Tumor Microenvironment
6.7K
Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
6.7K
Tumor Immunotherapy
554
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
554
Targeted Cancer Therapies
7.7K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.7K
